A collaboration between scientists at Rutgers and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson’s disease, a neurodegenerative disorder with no cure that affects 1 million people in the United States. To read the full article.
Recent Posts
- NASA at Princeton: Hands-on lab trains students in teamwork, building space equipment.
- Discovering a New Way to Measure Poverty.
- Rutgers’ Protein Data Bank Powers a New Era in Structural Biology.
- How Nature Can Make Urban Dwellers Healthier.
- How Better Software Choices Could Cut U.S. Health Care Costs.
Categories
- Community (2,377)
- Covid (992)
- CTO Events (6)
- News (3,014)
- Pilots (21)